Crossmark

A tumor treatment strategy based on biodegradable BSA@ZIF-8 for simultaneously ablating tumors and inhibiting infection

Crossref DOI link: https://doi.org/10.1039/C8NH00113H

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Wu, Qiong

Li, Mei

Tan, Longfei

Yu, Jie

Chen, Zengzhen

Su, Liuhui

Ren, Xiangling

Fu, Changhui

Ren, Jun

Li, Laifeng

Cao, Feng

Liang, Ping https://orcid.org/0000-0002-7640-2351
Zhang, Yu

Meng, Xianwei https://orcid.org/0000-0002-0350-4760
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (61671435)

National Natural Science Foundation of China (81671845)

National Natural Science Foundation of China (81630053)

Natural Science Foundation of Beijing Municipality (4161003)
License Information

Accepted Manuscript valid from 2019-07-11
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ping Liang (ORCID)

: Xianwei Meng (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 19 May 2018; Accepted 3 July 2018; Advance Article published 11 July 2018; Version of Record published 22 October 2018